Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.67%39.7M | -14.98%43.7M | 33.33%38.4M | -28.88%158.8M | 31.32%45.7M | -9.62%32.9M | -45.03%51.4M | -50.85%28.8M | 24.89%223.3M | -28.40%34.8M |
| Operating revenue | 24.32%36.8M | -14.98%43.7M | 33.33%38.4M | -28.88%158.8M | 59.20%55.4M | -18.68%29.6M | -45.03%51.4M | -50.85%28.8M | 24.89%223.3M | -28.40%34.8M |
| Cost of revenue | 10.63%28.1M | -22.49%32.4M | 84.36%50.7M | -47.83%138.5M | -27.12%43.8M | -49.20%25.4M | -56.50%41.8M | -53.63%27.5M | 63.18%265.5M | 6.00%60.1M |
| Gross profit | 54.67%11.6M | 17.71%11.3M | -1,046.15%-12.3M | 148.10%20.3M | 107.51%1.9M | 155.15%7.5M | 469.23%9.6M | 285.71%1.3M | -362.11%-42.2M | -212.35%-25.3M |
| Operating expense | 0.00%7.7M | 16.67%11.9M | -16.33%8.2M | 48.29%34.7M | 89.19%7M | 45.28%7.7M | 52.24%10.2M | 27.27%9.8M | -72.92%23.4M | -73.94%3.7M |
| Selling and administrative expenses | 0.00%7.2M | 17.00%11.7M | -16.13%7.8M | 53.46%33.3M | 106.06%6.8M | 50.00%7.2M | 56.25%10M | 29.17%9.3M | -38.00%21.7M | -75.91%3.3M |
| -General and administrative expense | 0.00%7.2M | 17.00%11.7M | -16.13%7.8M | 53.46%33.3M | 106.06%6.8M | 50.00%7.2M | 56.25%10M | 29.17%9.3M | -38.00%21.7M | -75.91%3.3M |
| Depreciation amortization depletion | 0.00%400K | 0.00%200K | -25.00%300K | -14.29%1.2M | -33.33%200K | 0.00%400K | -33.33%200K | 0.00%400K | -17.65%1.4M | -25.00%300K |
| -Depreciation and amortization | 0.00%400K | 0.00%200K | -25.00%300K | -14.29%1.2M | -33.33%200K | 0.00%400K | -33.33%200K | 0.00%400K | -17.65%1.4M | -25.00%300K |
| Other operating expenses | 0.00%100K | ---- | 0.00%100K | -33.33%200K | --0 | 0.00%100K | ---- | 0.00%100K | 0.00%300K | 0.00%100K |
| Operating profit | 2,050.00%3.9M | 0.00%-600K | -141.18%-20.5M | 78.05%-14.4M | 82.41%-5.1M | 98.94%-200K | 93.55%-600K | -1.19%-8.5M | 6.69%-65.6M | -30.04%-29M |
| Net non-operating interest income (expenses) | 35.83%-7.7M | 71.25%-2.3M | -47.13%-12.8M | 8.91%-32.7M | -56.86%-8M | -96.72%-12M | 0.00%-8M | 47.90%-8.7M | 6.02%-35.9M | 68.13%-5.1M |
| Non-operating interest income | -86.67%200K | -42.11%1.1M | 66.67%1M | -27.78%5.2M | -51.85%1.3M | -65.12%1.5M | 90.00%1.9M | 500.00%600K | -40.00%7.2M | 575.00%2.7M |
| Non-operating interest expense | -17.89%7.8M | -16.16%8.3M | -4.30%8.9M | 6.76%37.9M | 2.20%9.3M | -4.04%9.5M | 20.73%9.9M | 12.05%9.3M | -23.16%35.5M | -26.61%9.1M |
| Total other finance cost | -97.50%100K | -88.46%-4.9M | 476.92%4.9M | -102.63%-200K | ---- | 700.00%4M | -425.00%-2.6M | -115.29%-1.3M | 90.00%7.6M | ---1.3M |
| Other net income (expenses) | -197.95%-14.3M | 567.86%13.1M | 71.86%-6.5M | -159.39%-23.4M | 57.37%-8.1M | 1,522.22%14.6M | -115.14%-2.8M | -159.84%-23.1M | -77.07%39.4M | -160.13%-19M |
| Gain on sale of security | -85.35%2.3M | 77.27%-500K | 153.85%4.9M | -70.71%4.1M | 182.22%3.7M | 166.10%15.7M | -145.83%-2.2M | -222.97%-9.1M | 20.69%14M | -287.50%-4.5M |
| Special income (charges) | -228.57%-900K | 5,283.33%32.3M | --0 | -351.43%-8.8M | ---8.4M | --700K | -72.73%600K | -230.77%-1.7M | -81.96%3.5M | --0 |
| -Less:Restructuring and mergern&acquisition | 125.00%900K | 0.00%100K | --0 | --2.2M | --0 | --400K | --100K | --1.7M | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --8.4M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | -4,528.57%-32.4M | ---- | 48.57%-1.8M | --0 | ---1.1M | 68.18%-700K | ---- | 83.25%-3.5M | --0 |
| Income before tax | -854.17%-18.1M | 189.47%10.2M | 1.24%-39.8M | -13.53%-70.5M | 60.08%-21.2M | 109.96%2.4M | -1,050.00%-11.4M | -389.93%-40.3M | -198.10%-62.1M | -692.54%-53.1M |
| Income tax | 133.33%1.4M | -300.00%-200K | 33.33%800K | 18.18%2.6M | 333.33%1.3M | -14.29%600K | -88.89%100K | 100.00%600K | 650.00%2.2M | -50.00%300K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -1,028.57%-19.5M | 188.70%10.2M | -0.25%-40.6M | -12.69%-72.8M | 57.12%-22.9M | 108.47%2.1M | -3,933.33%-11.5M | -404.51%-40.5M | -201.73%-64.6M | -662.86%-53.4M |
| Net income continuous operations | -1,183.33%-19.5M | 190.43%10.4M | 0.73%-40.6M | -13.69%-73.1M | 57.87%-22.5M | 107.26%1.8M | -3,933.33%-11.5M | -400.74%-40.9M | -200.94%-64.3M | -631.51%-53.4M |
| Net income discontinuous operations | --0 | ---200K | --0 | 200.00%300K | ---400K | --300K | --0 | 233.33%400K | -50.00%-300K | --0 |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1,028.57%-19.5M | 188.70%10.2M | -0.25%-40.6M | -12.69%-72.8M | 57.12%-22.9M | 108.47%2.1M | -3,933.33%-11.5M | -404.51%-40.5M | -201.73%-64.6M | -662.86%-53.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -1,028.57%-19.5M | 188.70%10.2M | -0.25%-40.6M | -12.69%-72.8M | 57.12%-22.9M | 108.47%2.1M | -3,933.33%-11.5M | -404.51%-40.5M | -201.73%-64.6M | -662.86%-53.4M |
| Diluted earnings per share | -500.00%-0.04 | 166.67%0.02 | 0.00%-0.1 | -12.50%-0.18 | 61.54%-0.05 | 116.67%0.01 | -4,073.51%-0.03 | -433.33%-0.1 | -200.00%-0.16 | -550.00%-0.13 |
| Basic earnings per share | -500.00%-0.04 | 166.67%0.02 | 0.00%-0.1 | -12.50%-0.18 | 61.54%-0.05 | 116.67%0.01 | -4,073.51%-0.03 | -433.33%-0.1 | -200.00%-0.16 | -550.00%-0.13 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.